

The Pharma Industry registered 7% growth at MAT level where the Chronic therapies outperformed Acute therapies in 2022. Some of the key trends of Pharma Industry for the year 2022 are as below -
Chronic therapies displayed growth of 9% driven by growth from Cardiac, Anti-diabetes, Neuro and Respiratory segments.
Acute market reflected growth of 5% majorly due to growth from AI, Pain, Respiratory Acute and GI therapies.
Indian companies reflected faster rate of growth than MNCs.
Metros and Class I markets reflected better rate of growth than Extra urban markets.
Sitagliptin LoE resulted in the launch of 203 brands including plain and it's combinations.